Advertisement

Restless Legs Syndrome

An Overview With an Emphasis on Women
  • David M. Hiestand
  • Barbara Phillips
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

Restless legs syndrome (RLS) is a sensorimotor disorder that affects sleep in up to 15% of the population. Individuals experience uncomfortable sensations of the extremities, which occur with inactivity and are relieved with activity. Because of the circadian rhythmicity of these symptoms, RLS symptoms can interfere with sleep onset. Symptom descriptors are varied; some commonly used terms are “creepy-crawly,” “uncomfortable,” “pins and needles,” and “internal itch.” Regardless of the descriptor, symptoms of RLS include a compelling urge to move, as they are usually improved with movement, and patients frequently resort to flexing, stretching, and vigorous movement. The end result is typically poor quality of sleep, leading to excessive daytime somnolence and feelings of fatigue. Althugh the disorder affects both genders, it is more common in women (in most populations studied) and is associated with several medical conditions including uremia, anemia, diabetes, pregnancy, and menopause.

Keywords

Obstructive Sleep Apnea Periodic Limb Movement Unpleasant Sensation Periodic Limb Movement Disorder Periodic Limb Movement Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ekbom K., Restless legs: a clinical study. Ada Med Scand Suppl, 1945;158:1–123.Google Scholar
  2. 2.
    Walters A.S., Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord, 1995;10(5):634–642.PubMedCrossRefGoogle Scholar
  3. 3.
    Montplaisir J., M. Michaud, R. Denesle, and A. Gosselin, Periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairment. Sleep Med, 2000;l(2):163–167.CrossRefGoogle Scholar
  4. 4.
    Dorsey CM., S.E. Lukas, and S.L. Cunningham, Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology, 1996;14(6):437–442.PubMedCrossRefGoogle Scholar
  5. 5.
    Nofzinger E.A., A. Fasiczka, S. Berman, and M.E. Thase, Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry, 2000;61(11):858–862.PubMedCrossRefGoogle Scholar
  6. 6.
    Fantini M.L., M. Michaud, N. Gosselin, G. Lavigne, and J. Montplaisir, Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation. Neurology, 2002;59(12):1889–1894.PubMedGoogle Scholar
  7. 7.
    Exar E.N. and N.A. Collop, The association of upper airway resistance with periodic limb movements. Sleep, 2001;24(2):188–192.PubMedGoogle Scholar
  8. 8.
    Baran A.S., A.C. Richert, A.B. Douglass, W. May, and K. Ansarin, Change in periodic limb movement index during treatment of obstructive sleep apnea with continuous positive airway pressure. Sleep, 2003;26(6):717–720.PubMedGoogle Scholar
  9. 9.
    Phillips B., T. Young, L. Finn, K. Asher, W.A. Hening, and C. Purvis, Epidemiology of restless legs symptoms in adults. Arch Intern Med, 2000;60(14):2137–2141.CrossRefGoogle Scholar
  10. 10.
    Nichols D.A., R.P. Allen, J.H. Grauke, et al., Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med, 2003;63(19):2323–2329.CrossRefGoogle Scholar
  11. 11.
    Berger K, J. Luedemann, C. Trenkwalder, U. John, and C. Kessler, Sex and the risk of restless legs syndrome in the general population. Arch Intern Med, 2004;164(2):196–202.PubMedCrossRefGoogle Scholar
  12. 12.
    Kutner N.G. and D.L. Bliwise, Restless legs complaint in African-American and Caucasian hemodialysis patients. Sleep Med, 2002;3(6):497–500.PubMedCrossRefGoogle Scholar
  13. 13.
    Tan E.K., A. Seah, S.J. See, E. Lim, M.C. Wong, and K.K. Koh, Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord, 2001;16(3):577–579.PubMedCrossRefGoogle Scholar
  14. 14.
    Kageyama T, M. Kabuto H. Nitta, et al., Prevalences of periodic limb movement-like and restless legs-like symptoms among Japanese adults. Psychiatry Clin Neurosci, 2000;4(3):296–298.CrossRefGoogle Scholar
  15. 15.
    Bhowmik D., M. Bhatia, S. Gupta, S.K. Agarwal, S.C. Tiwari, and S.C. Dash, Restless legs syndrome in hemodialysis patients in India: a case controlled study. Sleep Med, 2003;4(2):143–146.PubMedCrossRefGoogle Scholar
  16. 16.
    Rajaram S.S., A.S. Walters, S.J. England, D. Mehta, and F. Nizam, Some children with growing pains may actually have restless legs syndrome. Sleep, 2004;27(4):767–773.PubMedGoogle Scholar
  17. 17.
    Walters A.S., D.L. Picchietti, B.L. Ehrenberg, and M.L. Wagner, Restless legs syndrome in childhood and adolescence. Pediatr Neurol, 1994;11(3):241–245.PubMedCrossRefGoogle Scholar
  18. 18.
    Hening W., R. Allen, C. Earley, C. Kushida, D. Icchietti, and M. Silber, The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep, 1999;22(7):970–999.PubMedGoogle Scholar
  19. 19.
    Ekbom K.A., Restless legs syndrome. Neurology, 1960;10:868–873.PubMedGoogle Scholar
  20. 20.
    O’Keeffe S.T., K. Gavin, and J.N. Lavan, Iron status and restless legs syndrome in the elderly. Age Ageing, 1994;23(3):200–203.PubMedCrossRefGoogle Scholar
  21. 21.
    Sun E.R., C.A. Chen, G. Ho, C.J. Earley, and R.P. Allen, Iron and the restless legs syndrome. Sleep, 1998;21(4):371–377.PubMedGoogle Scholar
  22. 22.
    Allen R.P., P.B. Barker, F. Wehrl, H.K. Song, and C.J. Earley, MRI measurement of brain iron in patients with restless legs syndrome. Neurology, 2001;56(2):263–265.PubMedGoogle Scholar
  23. 23.
    Tarquini B., Iron metabolism: clinical chroniological aspects. Chronobiologia, 1978;5:315–336.PubMedGoogle Scholar
  24. 24.
    Ruottinen H.M., M. Partinen, C. Hublin, et al., An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology, 2000;54(2):502–504.PubMedGoogle Scholar
  25. 25.
    Turjanski N., A.J. Lees, and D.J. Brooks, Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11 C-raclopride PET studies. Neurology, 1999;52(5):932–937.PubMedGoogle Scholar
  26. 26.
    Eisensehr I., T.C. Wetter, R. Linke, et al., Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology, 2001;57(7):1307–1309.PubMedGoogle Scholar
  27. 27.
    Michaud M., M. Dumont, B. Selmaoui, J. Paquet, M.L. Fantini, and J. Montplaisir, Circadian rhythm of restless legs syndrome: relationship with biological markers. Ann Neurol, 2004;55(3):372–380.PubMedCrossRefGoogle Scholar
  28. 28.
    Kunz D., and F. Bes, Exogenous melatonin in periodic limb movement disorder: an open clinical trial and a hypothesis. Sleep, 2001;24(2):183–187.PubMedGoogle Scholar
  29. 29.
    Tribl G.G., F. Waldhauser, T. Sycha, E. Auff, and J. Zeitlhofer, Urinary 6-hydroxy-melatonin-sulfate excretion and circadian rhythm in patients with restless legs syndrome. J Pineal Res, 2003;35(4):295–296.PubMedCrossRefGoogle Scholar
  30. 30.
    Ondo W. and J. Jankovic, Restless legs syndrome: clinicoetiologic correlates. Neurology, 1996;47(6):1435–1441.PubMedGoogle Scholar
  31. 31.
    Walters A.S., K. Hickey, J. Maltzman, et al., A questionnaire study of 138 patients with restless legs syndrome: the ‘Night-Walkers’ survey. Neurology, 1996;46(l):92–95.PubMedGoogle Scholar
  32. 32.
    Winkelmann J., T.C. Wetter, V. Collado-Seidel, et al., Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep, 2000;23(5):597–602.PubMedGoogle Scholar
  33. 33.
    Bassetti C.L., D. Mauerhofer, M. Gugger, J. Mathis, and C.W. Hess, Restless legs syndrome: a clinical study of 55 patients. Eur Neurol, 2001;45(2):67–74.PubMedCrossRefGoogle Scholar
  34. 34.
    Desai A.V., L.F. Cherkas, T.D. Spector, and A.J. Williams, Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study. Twin Res, 2004;7(6):589–595.PubMedCrossRefGoogle Scholar
  35. 35.
    Ondo W.G., K.D. Vuong, and Q. Wang, Restless legs syndrome in monozygotic twins: clinical correlates. Neurology, 2000;55(9):1404–1406.PubMedGoogle Scholar
  36. 36.
    Desautels A., G. Turecki, J. Montplaisir, A. Sequeira, A. Vemer, and G.A. Rouleau, Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet, 2001;69(6):1266–1270.PubMedCrossRefGoogle Scholar
  37. 37.
    Bonati M.T., L. Ferini-Strambi, P. Aridon, A. Oldani, M. Zucconi, and G. Casari, Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain, 2003;126(Pt 6):1485–1492.PubMedCrossRefGoogle Scholar
  38. 38.
    Paulson G.W. Restless legs syndrome. How to provide symptom relief with drug and nondrug therapies. Geriatrics, 2000;55(4):35–47.PubMedGoogle Scholar
  39. 39.
    Trenkwalder C, D. Garcia-Borreguero, P. Montagna, et al., Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. JNeurol Neurosurg Psychiatry, 2004;75(l):92–97.Google Scholar
  40. 40.
    Adler C.H., R.A. Hauser, K. Seth, et al., Ropinirole for restless legs syndrome: a placebo-controlled crossover trial. Neurology, 2004;62(8):1405–1407.PubMedGoogle Scholar
  41. 41.
    Lin S.C., J. Kaplan, CD. Burger, and P.A. Fredrickson, Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc, 1998;73(6):497–500.PubMedCrossRefGoogle Scholar
  42. 42.
    Becker P.M., W. Ondo, and D. Sharon, Encouraging initial response of restless legs syndrome to pramipexole. Neurology, 1998;51(4):1221–1223.PubMedGoogle Scholar
  43. 43.
    Montplaisir J., R. Denesle, and D. Petit, Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol, 2000;7(Suppl 1):27–31.PubMedCrossRefGoogle Scholar
  44. 44.
    Winkelman J.W. and L. Johnston, Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med, 2004;5(l):9–14.PubMedCrossRefGoogle Scholar
  45. 45.
    Walters A.S., J. Winkelmann, C. Trenkwalder, et al., Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord, 2001;16(6):1105–1109.PubMedCrossRefGoogle Scholar
  46. 46.
    Garcia-Borreguero D., O. Larrosa, de la LY, K. Verger, X. Masramon, and G. Hernandez, Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology, 2002;59(10):1573–1579.PubMedGoogle Scholar
  47. 47.
    Lee K.A., M.E. Zaffke, and K. Baratte-Beebe, Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med, 2001;10(4):335–341.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • David M. Hiestand
    • 1
  • Barbara Phillips
    • 1
  1. 1.Division of Pulmonary, Critical Care and Sleep MedicineUniversity of Kentucky Medical Center and Samaritan Sleep Disorders CenterLexington

Personalised recommendations